Curanex Pharmaceuticals CURX
NASDAQ CURX
$5.01 +0.39 (+8.43%)
As of: Oct 21, 2026 · 2:44 PM EDT

Curanex Pharmaceuticals (CURX) Enterprise Value (2025 - 2026)

Updated

Curanex Pharmaceuticals (CURX) recorded Enterprise Value of $4.58 million in Q2 2026.

Analysis

Curanex Pharmaceuticals (CURX) Enterprise Value (2025 - 2026) Analysis & Trends

On a TTM basis, Curanex Pharmaceuticals' Enterprise Value came in at -$6.33 million as of Jun 30, 2026; for FY2025, it came in at $4.41 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Curanex Pharmaceuticals 7.11 Mn -6.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.58 Mn
Dec 31, 2025 4.41 Mn
Sep 30, 2025 14.57 Mn
API Access

Curanex Pharmaceuticals Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=CURX&period=max&api_key=YOUR_API_KEY